Gene · 55215
FANCI: FA complementation group I
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FANCI: FA complementation group I. Genes, record 55215. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55215
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NVI1 | Fanconi anemia group I protein | 1,328 | 8 | Ensembl, GeneID, HGNC |
Source UniProt
Patents22
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026501822 A | 2026-01-16 | 7 | Q9NVI1 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 45848 | Q9NVI1 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4717 | Q9NVI1 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4288 | Q9NVI1 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4858 | Q9NVI1 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4288 | Q9NVI1 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4717 | Q9NVI1 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4858 | Q9NVI1 | Espacenet |
| US 11976334 B2 | 2024-05-07 | 152 | Q9NVI1 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 30673 | Q9NVI1 | Espacenet |
1 to 10 of 22
See all 22 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,231
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FANCI papers | Newest fiscal year |
|---|---|---|---|
| R01HL052725 | Molecular Pathogenesis of Fanconi Anemia | 21 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 20 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 16 | 2025 |
| ZIAHG000029 | Fanconi Anemia: Genotype-Phenotype Correlations | 11 | 2025 |
| R01CA168635 | Mechanistic Dissection of the BRCA1-SETX-dependent Pathway of R-loop Avoidance and Genome Maintenance | 10 | 2025 |
| ZIAAG000688 | Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins | 10 | 2025 |
| ZIAAG000746 | Repair of localized DNA damage | 10 | 2025 |
| ZIACP010144 | Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes | 10 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 8 | 2025 |
1 to 10 of 1,231Source NIH's project files
See all 1,231 nih grantsPapers1,818
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Perioperative and Clinicopathologic Outcomes of Patients with Young-Onset Renal Cell Carcinoma. | Clin Genitourin Cancer | 2026 | 42805854 | PubTator, text mining | PubMed |
| Severe Macrocytic Anemia Associated With a Novel ALAS2 Mutation: A Case Report and Literature Review. | Clin Case Rep | 2026 | 42757146 | PubTator, text mining | PubMed |
| FANCI: from genome guardian to translational therapeutic target. | Front Oncol | 2026 | 42444811 | PubTator, text mining | PubMed |
| Germline Predisposition in Pediatric Central Nervous System Tumors: Insights from a Multigene Panel Study. | Oncol Res | 2026 | 42232602 | PubTator, text mining | PubMed |
| Functional analysis of a splicing variant of the DOCK8 gene in a patient with breast cancer (Buryat ethnicity). | Asian Pac J Cancer Prev | 2026 | 42169560 | PubTator, text mining | PubMed |
| Integrative Bioinformatic Analysis Identifies Key Genes Driving Breast Cancer Brain Metastasis. | Diagnostics (Basel) | 2026 | 42072775 | PubTator, text mining | PubMed |
| Functional significance of miR-218 in lung cancer. | J Cancer Metastasis Treat | 2026 | 41924446 | PubTator, text mining | PubMed |
| Micronuclei: origins, assays, mechanisms, diseases and treatments. | Signal Transduct Target Ther | 2026 | 41888103 | PubTator, text mining | PubMed |
| An updated view on lagging strand DNA replication: implications for the replication stress response. | Cell Cycle | 2026 | 41865289 | PubTator, text mining | PubMed |
| EEPD1 evolved a unique DNA clamping dimer protecting reversed replication forks. | Nucleic Acids Res | 2026 | 41830330 | PubTator, text mining | PubMed |
1 to 10 of 1,818
See all 1,818 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55215
GET https://conductscience.org/api/genes/v1/55215/patents?page=2